soluble rage (srage (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
90
Structured Review
R&D Systems
soluble rage (srage
Soluble Rage (Srage, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/soluble+rage+(srage/soluble+rage/pmc09911595-230-32-35
Average 90 stars, based on 1 article reviews
Soluble Rage (Srage, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/soluble+rage+(srage/soluble+rage/pmc09911595-230-32-35
Average 90 stars, based on 1 article reviews
soluble rage (srage - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "The trajectory of osteoblast progenitor cells in patients with type 2 diabetes and the predictive model for their osteogenic differentiation ability"
Article Title: The trajectory of osteoblast progenitor cells in patients with type 2 diabetes and the predictive model for their osteogenic differentiation ability
Journal: Scientific Reports
doi: 10.1038/s41598-023-29677-8
Figure Legend Snippet: Clinical characteristics of the study participants.
Techniques Used:
Figure Legend Snippet: Clinical characteristics of the study participants with type 2 diabetes.
Techniques Used:
Related Articles
Inhibition:Article Title: Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Article Snippet: Tumor necrosis factor-alpha (TNF-a) (Sigma-Aldrich, T-6674) was added to a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.).a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.). ... To investigate the effect of RAGE on cell proliferation, HUVECs were treated with an anti-RAGE antibody (20 lg/ml for 3 h) (Millipore, MAB5328) or Recombinant:Article Title: Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Article Snippet: Tumor necrosis factor-alpha (TNF-a) (Sigma-Aldrich, T-6674) was added to a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.).a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.). ... To investigate the effect of RAGE on cell proliferation, HUVECs were treated with an anti-RAGE antibody (20 lg/ml for 3 h) (Millipore, MAB5328) or Infection:Article Title: Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Article Snippet: Tumor necrosis factor-alpha (TNF-a) (Sigma-Aldrich, T-6674) was added to a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.).a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.). ... To investigate the effect of RAGE on cell proliferation, HUVECs were treated with an anti-RAGE antibody (20 lg/ml for 3 h) (Millipore, MAB5328) or Expressing:Article Title: Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Article Snippet: Tumor necrosis factor-alpha (TNF-a) (Sigma-Aldrich, T-6674) was added to a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.).a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.). ... To investigate the effect of RAGE on cell proliferation, HUVECs were treated with an anti-RAGE antibody (20 lg/ml for 3 h) (Millipore, MAB5328) or Control:Article Title: Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Article Snippet: Tumor necrosis factor-alpha (TNF-a) (Sigma-Aldrich, T-6674) was added to a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.).a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.). ... To investigate the effect of RAGE on cell proliferation, HUVECs were treated with an anti-RAGE antibody (20 lg/ml for 3 h) (Millipore, MAB5328) or MTS Assay:Article Title: Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Article Snippet: Tumor necrosis factor-alpha (TNF-a) (Sigma-Aldrich, T-6674) was added to a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.).a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.). ... To investigate the effect of RAGE on cell proliferation, HUVECs were treated with an anti-RAGE antibody (20 lg/ml for 3 h) (Millipore, MAB5328) or One-tailed Test:Article Title: Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Article Snippet: Tumor necrosis factor-alpha (TNF-a) (Sigma-Aldrich, T-6674) was added to a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.).a final concentration of 5 ng/ml and incubated for 24 h. HUVECs were treated with various concentrations of recombinant psoriasin protein (Abnova) (0.15–10 lg/ml) or with recombinant VEGF protein (Invitrogen, PHC9394) (10 ng/ml) for 24 and 48 h. HUVECs were visualized using a Leica DMRXA Widefield Microscope (Leica Microsystems Inc.). ... To investigate the effect of RAGE on cell proliferation, HUVECs were treated with an anti-RAGE antibody (20 lg/ml for 3 h) (Millipore, MAB5328) or |
